Senate Passes GMO Labeling Bill

The legislation will now go to the US House of Representatives, where it will likely pass.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, USDAConsumers may soon have access to information indicating if their food products include ingredients that are genetically modified. Last week (July 7) the US Senate voted 63 to 30 in favor of passing a bill to federally mandate the labeling of foods that contain genetically modified organisms (GMOs).

Critics of the bill don’t like key parts of the legislation. There are no penalties for manufacturers who fail to comply with the mandate. And the bill only requires food companies to include a US Department of Agriculture (USDA) symbol indicating the presence of a GMO in the product or a QR code that links smartphone users to ingredient information, rather than explicitly listing the GMO ingredients. According to Science, Senator Patrick Leahy (D-VT)—whose state passed a GMO labeling bill that went into effect on July 1—called the bill “a farce of a proposal.”

“It certainly is not perfect, from my perspective,” said Pat Roberts (R-KS), one of the architects of the bill, “but it is the best bill possible under these difficult circumstances we ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies